CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Aged care shares take a hit amid Australian government inquiry into industry

Australia’s leading aged-care providers’ shares have plummeted, after Prime Minister Scott Morrison announced a government inquiry investigating the aged-care industry.

IG Analyst

Publication date : 2018-09-17T06:12:44+0100

Healthcare

Source: Bloomberg

Mr Morrison announced the inquiry on Sunday, upon what he described as ‘’alarming and disturbing’’ spikes in elder abuse.

Leading providers lost as much as $318 million in market value on Monday after the announcement. Japara Healthcare Ltd stocks dropped 21%, Estia Health Ltd fell 17% and Regis Healthcare Ltd tumbled 20% upon the news.

Fisher & Paykel Healthcare Corporation Ltd also fell 1.3% while Ryman Healthcare Ltd dropped 0.4 %. The wider health care index was down 0.9 %.

The inquiry into the aged-care industry will investigate quality of care in residential facilities to elderly Australians and people with disabilities. This comes after Mr Morrison said the government had discovered malpractice in the industry including abuse and poor quality of care.

Annual government spending on aged care is expected to rise to $23 billion by 2023. According to GEN aged care data, government spending on aged care services has progressively increased each year since 2011-12.

In 2016 – 2017, governments spent an estimated $17 billion on aged care, with 69% towards residential aged care.

The call to action comes after authorities say they’ve shut at least one aged care facility a month since the Oakden nursing home scandal in April 2017.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IG Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.

Find articles by writer

Disclaimer:

All forms of investments carry risks and trading CFDs may not be suitable for everyone. CFDs are leveraged instruments and can result in losses that exceed deposits, so please ensure that you fully understand, and are aware of, the risks and costs involved. Refer to the Risk Disclosure Statement and Risk Fact Sheet.

IG Asia Pte Ltd (Co.Reg.No. 200510021K) is regulated by the Monetary Authority of Singapore and holds a capital markets services licence for dealing in capital markets products that are over-the-counter derivatives contracts and is an exempt financial adviser.

IG provides an execution-only service. The information in this advertisement does not contain (and should not be construed as containing) investment advice or an investment recommendation, or an offer of or solicitation for a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. You should consider your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

The information on this site is not directed at residents of the United States or Belgium and is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

This advertisement has not been reviewed by the Monetary Authority of Singapore.